Detalhe da pesquisa
1.
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Clin Chem
; 70(1): 273-284, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175592
2.
In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program.
Haematologica
; 108(1): 196-206, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734926
3.
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.
Am J Hematol
; 97(5): 583-591, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170780
4.
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
Am J Hematol
; 97(12): 1538-1547, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087071
5.
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.
Blood
; 133(1): 81-93, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446494
6.
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma.
Blood
; 134(9): 761-764, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300404
7.
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma.
Br J Haematol
; 190(6): 864-868, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510594
8.
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
Blood
; 132(16): 1695-1702, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126979
9.
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
Blood
; 131(2): 226-235, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122756
10.
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Blood
; 131(18): 2036-2046, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467182
11.
Can histologic transformation of follicular lymphoma be predicted and prevented?
Blood
; 130(3): 258-266, 2017 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408460
12.
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.
Blood
; 129(20): 2760-2770, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351934
13.
Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
J Pathol
; 244(5): 598-609, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359812
14.
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Blood
; 127(18): 2182-8, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834242
15.
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy.
Blood
; 128(8): 1112-20, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418643
16.
Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience.
Haematologica
; 108(4): 1186-1189, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453110
17.
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Br J Haematol
; 176(2): 210-221, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739058
18.
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup.
Blood
; 125(6): 959-66, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395426
19.
Cell of origin of transformed follicular lymphoma.
Blood
; 126(18): 2118-27, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26307535
20.
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
PLoS Med
; 13(12): e1002197, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959929